Riskpilot← Back to searchSign inGet full accessAB SCIEX AS
ASActiveOrg 992425458Haakon Viis Gate 6, 0161 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20080 employees
Revenue 2024
NOK 11,8M
+64% vs 2023
EBITDA margin
6.1%
+50% vs 2023
Equity ratio
87.2%
Financial strength
Net profit 2024
NOK 2M
+31% vs 2023
| Revenue | NOK 11,8M | +64% |
| EBITDA | NOK 718K | +50% |
| Net profit | NOK 2M | +31% |
| Total assets | NOK 48,7M | +10% |
| Equity | NOK 42,5M | +5% |
| Employees | 0 | — |
Legal name
AB SCIEX AS
Org number
992425458
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26. mars 2008
Share capital
NOK 220 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Erverve næringsvirksomhet gjennom kjøp og salg av selskapsandeler og /eller kjøp og salg av eiendeler, rettigheter og forpliktelser, samt alt som hermed er forbundet, herunder å gi lån og stille garantier i forindelse med slik virksomhet, samt utvikle, fremstille, markedsføre og selge analystisk intrumentering, forbruksvarer og tjenester og dertil knyttede produkter og tjenester.
Address
Haakon Viis Gate 6, 0161 Oslo
Email
contactuschina@sciex.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 400 | 15 940 | 6 345 | 7 206 | 11 830 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 294 | 604 | 216 | 480 | 718 |
| Depreciation & amort. | −7 | −0 | −0 | −0 | −0 |
| EBIT | 287 | 604 | 216 | 480 | 718 |
| Net financials | 209 | 203 | 824 | 1 479 | 1 870 |
| Profit before tax | 497 | 807 | 1 040 | 1 959 | 2 588 |
| Tax | 112 | −0 | −0 | −0 | −0 |
| Net profit | 384 | 593 | 863 | 1 524 | 1 995 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 44 315 | 52 388 | 41 302 | 44 183 | 48 690 |
| Equity | 37 477 | 38 071 | 38 933 | 40 458 | 42 453 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 837 | 14 317 | 2 369 | 3 725 | 6 237 |
| Total debt | 6 837 | 14 317 | 2 369 | 3 725 | 6 237 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20202024
Equity ratio
87.2%
This company
38.2%
Market median
+128% vs market
20202024
Return on equity
4.7%
This company
18.4%
Market median
-74% vs market
20202024
Net profit margin
16.9%
This company
8.1%
Market median
+109% vs market
20202024
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KP Contact Person | Contact Person | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Salsnes Filter As
AB SCIEX AS Board members of AB SCIEX AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kevin Paul Smith | Contact Person | 0 companies |
| Inese Lowenstein | Board of Directors | 0 companies |
| Klaus Christian Sauber | Board of Directors | 0 companies |
| Juan Martin Wolpert | Chairman | 0 companies |
| Joseph Patrick Fox | Board of Directors | 0 companies |
| Marcel Johan Eijsackers | Board of Directors | 0 companies |